FEATURED COMPANIES
- Agilent Technologies
- BioGenex Laboratories
- Cardinal Health
- Danaher Corporation
- Epridea
- NeoGenomics Laboratories
Anatomic Pathology Equipment and Consumables Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment & consumables market.
This report focuses on anatomic pathology equipment and consumables market which is experiencing strong growth. The report gives a guide to the anatomic pathology equipment & consumables market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the anatomic pathology equipment & consumables? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anatomic Pathology Equipment & Consumables market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anatomic pathology equipment & consumables market, and compares it with other markets.
Scope
Markets Covered:
1) By Products & Services: Instruments; Consumables; Services
2) By Application: Disease Diagnosis; Cancer; Other Diseases; Medical Research
3) By End-use : Hospital Laboratories; Clinical Laboratories; Others
Companies Mentioned: Epridea; F. Hoffmann-La Roche Ltd.; DanaherCorporation; Thermo Fisher Scientific; Sakura Finetek
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
This report focuses on anatomic pathology equipment and consumables market which is experiencing strong growth. The report gives a guide to the anatomic pathology equipment & consumables market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the anatomic pathology equipment & consumables? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anatomic Pathology Equipment & Consumables market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anatomic pathology equipment & consumables market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The anatomic pathology equipment and consumables market section of the report gives context. It compares the anatomic pathology equipment and consumables market with other segments of the anatomic pathology equipment and consumables market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, anatomic pathology equipment and consumables indicators comparison.
Scope
Markets Covered:
1) By Products & Services: Instruments; Consumables; Services
2) By Application: Disease Diagnosis; Cancer; Other Diseases; Medical Research
3) By End-use : Hospital Laboratories; Clinical Laboratories; Others
Companies Mentioned: Epridea; F. Hoffmann-La Roche Ltd.; DanaherCorporation; Thermo Fisher Scientific; Sakura Finetek
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Anatomic Pathology Equipment and Consumables Market
What is the estimated value of the Global Anatomic Pathology Equipment and Consumables Market?
What is the growth rate of the Global Anatomic Pathology Equipment and Consumables Market?
What is the forecasted size of the Global Anatomic Pathology Equipment and Consumables Market?
Who are the key companies in the Global Anatomic Pathology Equipment and Consumables Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Agilent Technologies
- BioGenex Laboratories
- Cardinal Health
- Danaher Corporation
- Epridea
- NeoGenomics Laboratories
1. Executive Summary2. Anatomic Pathology Equipment And Consumables Market Characteristics26. Key Mergers And Acquisitions In The Anatomic Pathology Equipment And Consumables Market27. Anatomic Pathology Equipment And Consumables Market Trends And Strategies28. Anatomic Pathology Equipment And Consumables Market Future Outlook and Potential Analysis
3. Anatomic Pathology Equipment And Consumables Market Size And Growth
4. Anatomic Pathology Equipment And Consumables Market Segmentation
5. Anatomic Pathology Equipment And Consumables Market Regional And Country Analysis
6. Asia-Pacific Anatomic Pathology Equipment And Consumables Market
7. China Anatomic Pathology Equipment And Consumables Market
8. India Anatomic Pathology Equipment And Consumables Market
9. Japan Anatomic Pathology Equipment And Consumables Market
10. Australia Anatomic Pathology Equipment And Consumables Market
11. Indonesia Anatomic Pathology Equipment And Consumables Market
12. South Korea Anatomic Pathology Equipment And Consumables Market
13. Western Europe Anatomic Pathology Equipment And Consumables Market
14. UK Anatomic Pathology Equipment And Consumables Market
15. Germany Anatomic Pathology Equipment And Consumables Market
16. France Anatomic Pathology Equipment And Consumables Market
17. Eastern Europe Anatomic Pathology Equipment And Consumables Market
18. Russia Anatomic Pathology Equipment And Consumables Market
19. North America Anatomic Pathology Equipment And Consumables Market
20. USA Anatomic Pathology Equipment And Consumables Market
21. South America Anatomic Pathology Equipment And Consumables Market
22. Brazil Anatomic Pathology Equipment And Consumables Market
23. Middle East Anatomic Pathology Equipment And Consumables Market
24. Africa Anatomic Pathology Equipment And Consumables Market
25. Anatomic Pathology Equipment And Consumables Market Competitive Landscape And Company Profiles
29. Appendix
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Agilent Technologies
- BioGenex Laboratories
- Cardinal Health
- Danaher Corporation
- Epridea
- NeoGenomics Laboratories
Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated.
The global anatomic pathology equipment and consumables market is expected to decline from $17.26 billion in 2019 to $16.47 billion in 2020 at a compound annual growth rate (CAGR) of -4.58%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $21.03 billion in 2023 at a CAGR of 8.5%.
The anatomical pathology equipment and consumables market consists of sales of anatomical pathology equipment and consumables and related services by entities (organizations, sole traders and partnerships) that manufacture anatomical pathology equipment and consumables to diagnose diseases. Anatomic pathology is a branch of science in which the diagnosis of the disease is carried out by examining tissues and organs at a molecular, biochemical, and microscopic level.
North America was the largest region in the anatomic pathology equipment and consumables market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
In June 2019, PHC Holdings Corporation acquired the anatomical pathology business of Thermo Fisher Scientific Inc for $1.14 billion. The acquired anatomical pathology business is expected to work as a new self-governing business named Epredia that will proceed to work as a leading global provider of comprehensive solutions in the anatomical pathology field, including instruments, consumables, and microscope slides.
The anatomic pathology equipment market and consumables market covered in this report is segmented by products & services into instruments; consumables; services, by application into disease diagnosis; cancer; other diseases; medical research and by end-use into hospital laboratories; clinical laboratories; others.
The shortage of skilled professionals in clinical and diagnostic laboratories is hindering the anatomical pathology equipment and consumables market. Anatomic pathology testing requires specialized skillsets relating to life sciences, pharmaceuticals, electronics and software. These skillsets are available to a limited number of organizations, most of which are located in the USA and Europe. Lack of trained manpower capable of performing molecular biology experiments and interpreting the results is a major limitation in the testing and confinement of anatomic pathology equipment in developing countries. For the few laboratory experts present in these countries, priority is given to other medical emergencies such as heart attacks and road accidents. This shortage of skilled labor is expected to be a significant deterrent to the growth of the market during the forecast period.
Companies in the anatomic pathology equipment and consumables market are increasingly investing in new technologies for better efficiency and reducing the time taken to conduct these tests. Companies such as Biogenex have developed automated staining technology such as Xmatrx and i6000 diagnostics for diverse laboratory needs. Xmatrx systems offer standardized processes from baking through final glass coverslip for staining and prevent cross-contamination and i6000 diagnostics is a high-throughput system for special staining of clinical samples in molecular pathology laboratories. The i6000 diagnostics possesses a staining capacity of 200 slides in 8 hours (60 slides in 3 hours).
The rising occurrence of chronic diseases such as cancer is expected to drive the demand for the anatomic pathology equipment and consumables market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for anatomic pathology equipment and consumables market.
The global anatomic pathology equipment and consumables market is expected to decline from $17.26 billion in 2019 to $16.47 billion in 2020 at a compound annual growth rate (CAGR) of -4.58%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $21.03 billion in 2023 at a CAGR of 8.5%.
The anatomical pathology equipment and consumables market consists of sales of anatomical pathology equipment and consumables and related services by entities (organizations, sole traders and partnerships) that manufacture anatomical pathology equipment and consumables to diagnose diseases. Anatomic pathology is a branch of science in which the diagnosis of the disease is carried out by examining tissues and organs at a molecular, biochemical, and microscopic level.
North America was the largest region in the anatomic pathology equipment and consumables market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
In June 2019, PHC Holdings Corporation acquired the anatomical pathology business of Thermo Fisher Scientific Inc for $1.14 billion. The acquired anatomical pathology business is expected to work as a new self-governing business named Epredia that will proceed to work as a leading global provider of comprehensive solutions in the anatomical pathology field, including instruments, consumables, and microscope slides.
The anatomic pathology equipment market and consumables market covered in this report is segmented by products & services into instruments; consumables; services, by application into disease diagnosis; cancer; other diseases; medical research and by end-use into hospital laboratories; clinical laboratories; others.
The shortage of skilled professionals in clinical and diagnostic laboratories is hindering the anatomical pathology equipment and consumables market. Anatomic pathology testing requires specialized skillsets relating to life sciences, pharmaceuticals, electronics and software. These skillsets are available to a limited number of organizations, most of which are located in the USA and Europe. Lack of trained manpower capable of performing molecular biology experiments and interpreting the results is a major limitation in the testing and confinement of anatomic pathology equipment in developing countries. For the few laboratory experts present in these countries, priority is given to other medical emergencies such as heart attacks and road accidents. This shortage of skilled labor is expected to be a significant deterrent to the growth of the market during the forecast period.
Companies in the anatomic pathology equipment and consumables market are increasingly investing in new technologies for better efficiency and reducing the time taken to conduct these tests. Companies such as Biogenex have developed automated staining technology such as Xmatrx and i6000 diagnostics for diverse laboratory needs. Xmatrx systems offer standardized processes from baking through final glass coverslip for staining and prevent cross-contamination and i6000 diagnostics is a high-throughput system for special staining of clinical samples in molecular pathology laboratories. The i6000 diagnostics possesses a staining capacity of 200 slides in 8 hours (60 slides in 3 hours).
The rising occurrence of chronic diseases such as cancer is expected to drive the demand for the anatomic pathology equipment and consumables market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for anatomic pathology equipment and consumables market.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Epridea
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Thermo Fisher Scientific
- Sakura Finetek
- Agilent Technologies
- Danaher Corporation
- Bio SB
- BioGenex Laboratories
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- NeoGenomics Laboratories
- Ventana Medical Systems, Inc
- Cardinal Health
- Dianon Systems, Inc
- Bio-Rad Laboratories Inc
Note: Product cover images may vary from those shown
LOADING...